Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MetaVia ( (MTVA) ) has shared an announcement.
On May 8, 2025, MetaVia Inc. entered into a securities purchase agreement with institutional accredited investors for a private placement, resulting in gross proceeds of approximately $10 million. The company plans to use the net proceeds for working capital and to continue clinical development of DA-1726 for obesity treatment. The private placement closed on May 14, 2025, with Ladenburg Thalmann & Co. Inc. acting as the exclusive placement agent. The securities were issued under Section 4(a)(2) and Regulation D of the Securities Act of 1933, and MetaVia has agreed to file a registration statement with the SEC for the resale of shares.
The most recent analyst rating on (MTVA) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on MetaVia stock, see the MTVA Stock Forecast page.
Spark’s Take on MTVA Stock
According to Spark, TipRanks’ AI Analyst, MTVA is a Underperform.
MetaVia’s overall stock score is heavily impacted by its poor financial performance, characterized by persistent losses and no revenue generation. The technical analysis indicates weak market momentum, and negative valuation metrics highlight the stock’s high-risk profile. Although recent positive trial results provide some potential for future growth, significant strategic changes are necessary for the company to achieve financial stability and investor confidence.
To see Spark’s full report on MTVA stock, click here.
More about MetaVia
MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is developing DA-1726 for the treatment of obesity and DA-1241 for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Average Trading Volume: 528,435
Technical Sentiment Signal: Sell
Current Market Cap: $7.07M
See more insights into MTVA stock on TipRanks’ Stock Analysis page.